Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AGCO CORP /DEAGCO · Entity 3615 | Sr.VP Global Grain and Protein | February 12, 2019 | February 14, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AGCO CORP /DE
Report date February 12, 2019 · Filed February 14, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 28,854 |
Ending reported balance
After 2019-02-12 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-02-12 · Exercise / conversion · Acquired 1,500 · Balance 30,183 Row 2 · 2019-02-12 · Tax withholding · Disposed 1,329 · Balance 28,854 |
| Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $51.37 · Expires 2019-02-17 | Direct | 0 |
Reported balance
After 2019-02-12 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-02-12 · Exercise / conversion · Disposed 1,500 · Balance 0 F1: Exercisable in four equal annual installments beginning February 17, 2013. |
Filing footnotes · ownership attribution and instrument terms
F1: Exercisable in four equal annual installments beginning February 17, 2013.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 12, 2019 Filed Feb 14, 2019 20:17 UTC | AGCO CORP /DE AGCO · Entity 3615 | Exercise / conversionStock Appreciation Right · Derivative | 1,500 | $0.00 Strike: $51.37 | $0.00 |
DisclosureSEC source: 0001209191-19-010072 · doc4.xml · derivative · entry 3 Welke Thomas Frederick · CIK 0001560746 · Sr.VP Global Grain and Protein 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2019-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Exercisable in four equal annual installments beginning February 17, 2013. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 20:17 UTC | AGCO CORP /DE AGCO · Entity 3615 | Tax withholdingCommon Stock | 1,329 | $64.48 | $85,693.92 |
DisclosureSEC source: 0001209191-19-010072 · doc4.xml · nonDerivative · entry 2 Welke Thomas Frederick · CIK 0001560746 · Sr.VP Global Grain and Protein 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,854 Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 20:17 UTC | AGCO CORP /DE AGCO · Entity 3615 | Exercise / conversionCommon Stock | 1,500 | $51.37 | $77,055.00 |
DisclosureSEC source: 0001209191-19-010072 · doc4.xml · nonDerivative · entry 1 Welke Thomas Frederick · CIK 0001560746 · Sr.VP Global Grain and Protein 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,183 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 20:35 UTC | AGCO CORP /DE AGCO · Entity 3615 | Tax withholdingCommon Stock | 7,059 | $63.40 | $447,540.60 |
DisclosureSEC source: 0001209191-19-009246 · doc4.xml · nonDerivative · entry 4 Welke Thomas Frederick · CIK 0001560746 · Sr.VP Global Grain and Protein 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,683 Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 20:35 UTC | AGCO CORP /DE AGCO · Entity 3615 | GrantCommon Stock | 2,533 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-009246 · doc4.xml · nonDerivative · entry 3 Welke Thomas Frederick · CIK 0001560746 · Sr.VP Global Grain and Protein 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,742 F3 · shares: Represents the minimum number of shares that will be issued to the reporting person upon the completion of the 2018-2020 performance cycle based upon partial satisfaction of vesting criteria for a performance based award. Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 20:35 UTC | AGCO CORP /DE AGCO · Entity 3615 | GrantCommon Stock | 3,066 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-009246 · doc4.xml · nonDerivative · entry 2 Welke Thomas Frederick · CIK 0001560746 · Sr.VP Global Grain and Protein 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,209 F2 · shares: Represents the minimum number of shares that will be issued to the reporting person upon the completion of the 2017-2019 performance cycle based upon partial satisfaction of vesting criteria for a performance based award. Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 20:35 UTC | AGCO CORP /DE AGCO · Entity 3615 | GrantCommon Stock | 3,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-009246 · doc4.xml · nonDerivative · entry 1 Welke Thomas Frederick · CIK 0001560746 · Sr.VP Global Grain and Protein 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,143 F1 · shares: Represents the number of shares issued to the reporting person upon completion of the 2016 - 2018 performance cycle based upon satisfaction of the vesting criteria for a performance based award at the 155.666% level. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 19:37 UTC | AGCO CORP /DE AGCO · Entity 3615 | GrantStock Appreciation Right · Derivative | 8,600 | $0.00 Strike: $64.71 | $0.00 |
DisclosureSEC source: 0001209191-19-005109 · doc4.xml · derivative · entry 2 Welke Thomas Frederick · CIK 0001560746 · Sr.VP Global Grain and Protein 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,600 Underlying: Common Stock · 8,600 shares Expires 2026-01-22 F2 · derivative.exercise_date: Exercisable in four equal annual installments beginning January 22, 2020. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 19:37 UTC | AGCO CORP /DE AGCO · Entity 3615 | GrantCommon Stock | 2,040 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-005109 · doc4.xml · nonDerivative · entry 1 Welke Thomas Frederick · CIK 0001560746 · Sr.VP Global Grain and Protein 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,993 F1 · price: The reporting person was awarded restricted stock units that will vest in three equal annual installments beginning on January 22, 2020. Each restricted stock unit represents the contingent right to receive one share of common stock. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 20:42 UTC | AGCO CORP /DE AGCO · Entity 3615 | Exercise / conversionStock Appreciation Right · Derivative | 1,000 | $0.00 Strike: $52.94 | $0.00 |
DisclosureSEC source: 0001209191-18-060210 · doc4.xml · derivative · entry 3 Welke Thomas Frederick · CIK 0001560746 · Sr.VP Global Grain and Protein 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2019-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Exercisable in four equal annual installments beginning January 25, 2013. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 20:42 UTC | AGCO CORP /DE AGCO · Entity 3615 | Tax withholdingCommon Stock | 950 | $58.29 | $55,375.50 |
DisclosureSEC source: 0001209191-18-060210 · doc4.xml · nonDerivative · entry 2 Welke Thomas Frederick · CIK 0001560746 · Sr.VP Global Grain and Protein 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,953 Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 20:42 UTC | AGCO CORP /DE AGCO · Entity 3615 | Exercise / conversionCommon Stock | 1,000 | $52.94 | $52,940.00 |
DisclosureSEC source: 0001209191-18-060210 · doc4.xml · nonDerivative · entry 1 Welke Thomas Frederick · CIK 0001560746 · Sr.VP Global Grain and Protein 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,903 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 18:44 UTC | AGCO CORP /DE AGCO · Entity 3615 | GrantCommon Stock | 3,068 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-015449 · doc4.xml · nonDerivative · entry 2 Welke Thomas Frederick · CIK 0001560746 · Sr.VP Global Grain and Protein 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,903 F2 · shares: Represents the minimum number of shares that will be issued to the reporting person upon the completion of the 2017-2019 performance cycle based upon partial satisfaction of vesting criteria for a performance based award. F2 · price: Represents the minimum number of shares that will be issued to the reporting person upon the completion of the 2017-2019 performance cycle based upon partial satisfaction of vesting criteria for a performance based award. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 18:44 UTC | AGCO CORP /DE AGCO · Entity 3615 | GrantCommon Stock | 2,658 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-015449 · doc4.xml · nonDerivative · entry 1 Welke Thomas Frederick · CIK 0001560746 · Sr.VP Global Grain and Protein 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,835 F1 · shares: Represents the minimum number of shares that will be issued to the reporting person upon the completion of the 2016-2018 performance cycle based upon partial satisfaction of vesting criteria for a performance based award. F1 · price: Represents the minimum number of shares that will be issued to the reporting person upon the completion of the 2016-2018 performance cycle based upon partial satisfaction of vesting criteria for a performance based award. Read SEC document |
| February 08, 2018 Filed Feb 9, 2018 22:38 UTC | AGCO CORP /DE AGCO · Entity 3615 | Tax withholdingCommon Stock | 536 | $67.70 | $36,287.20 |
DisclosureSEC source: 0001209191-18-008950 · doc4.xml · nonDerivative · entry 1 Welke Thomas Frederick · CIK 0001560746 · Sr.VP Global Grain and Protein 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,177 Read SEC document |
| January 23, 2018 Filed Jan 25, 2018 17:32 UTC | AGCO CORP /DE AGCO · Entity 3615 | GrantStock Appreciation Right · Derivative | 5,000 | $0.00 Strike: $73.14 | $0.00 |
DisclosureSEC source: 0001209191-18-005328 · doc4.xml · derivative · entry 2 Welke Thomas Frederick · CIK 0001560746 · Sr.VP Global Grain and Protein 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2025-01-23 F3 · derivative.exercise_date: Exercisable in four equal annual installments beginning January 23, 2019. Read SEC document |
| January 23, 2018 Filed Jan 25, 2018 17:32 UTC | AGCO CORP /DE AGCO · Entity 3615 | GrantCommon Stock | 1,326 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-005328 · doc4.xml · nonDerivative · entry 1 Welke Thomas Frederick · CIK 0001560746 · Sr.VP Global Grain and Protein 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,713 F1 · price: The reporting person was awarded restricted stock units that will vest in three equal annual installments beginning on January 23, 2019. Each restricted stock unit represents the contingent right to receive one share of common stock. F2 · balance_after: Includes 4 shares representing dividend equivalents accrued through the transaction date in the form of additional restricted stock units that vest and are paid at the same time and in the same manner as the underlying restricted stock units originally awarded on January 21, 2015 and reported on Form 4 filed on January 23, 2015. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 18:43 UTC | AGCO CORP /DE AGCO · Entity 3615 | GrantCommon Stock | 2,752 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015671 · doc4.xml · nonDerivative · entry 1 Welke Thomas Frederick · CIK 0001560746 · Sr.VP Global Grain and Protein 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,383 F1 · shares: Represents the minimum number of shares that will be issued to the reporting person upon the completion of the 2016-2018 performance cycle based upon partial satisfaction of vesting criteria for a performance based award. F1 · price: Represents the minimum number of shares that will be issued to the reporting person upon the completion of the 2016-2018 performance cycle based upon partial satisfaction of vesting criteria for a performance based award. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 16:29 UTC | AGCO CORP /DE AGCO · Entity 3615 | GrantCommon Stock | 9,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-010953 · doc4.xml · nonDerivative · entry 1 Welke Thomas Frederick · CIK 0001560746 · Sr.VP Global Grain and Protein 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,631 F1 · price: Upon the achievement of performance criteria, the reporting person was awarded restricted stock units that will vest on December 31, 2018. Each restricted stock unit represents the contingent right to receive one share of common stock. Read SEC document |
| February 09, 2017 Filed Feb 10, 2017 22:17 UTC | AGCO CORP /DE AGCO · Entity 3615 | Tax withholdingCommon Stock | 500 | $64.32 | $32,160.00 |
DisclosureSEC source: 0001209191-17-009646 · doc4.xml · nonDerivative · entry 1 Welke Thomas Frederick · CIK 0001560746 · Sr.VP Global Grain and Protein 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,556 Read SEC document |
| January 24, 2017 Filed Jan 26, 2017 18:01 UTC | AGCO CORP /DE AGCO · Entity 3615 | GrantStock Appreciation Right · Derivative | 6,200 | $0.00 Strike: $63.47 | $0.00 |
DisclosureSEC source: 0001209191-17-005671 · doc4.xml · derivative · entry 2 Welke Thomas Frederick · CIK 0001560746 · Sr.VP Global Grain and Protein 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,200 Underlying: Common Stock · 6,200 shares Expires 2024-01-24 F3 · derivative.exercise_date: Exercisable in four equal annual installments beginning January 24, 2018. Read SEC document |
| January 24, 2017 Filed Jan 26, 2017 18:01 UTC | AGCO CORP /DE AGCO · Entity 3615 | GrantCommon Stock | 1,530 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-005671 · doc4.xml · nonDerivative · entry 1 Welke Thomas Frederick · CIK 0001560746 · Sr.VP Global Grain and Protein 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,056 F1 · price: The reporting person was awarded restricted stock units that will vest in three equal annual installments beginning on January 24, 2018. Each restricted stock unit represents the contingent right to receive one share of common stock. F2 · balance_after: Includes 8 shares representing dividend equivalents accrued through the transaction date in the form of additional restricted stock units that vest and are paid at the same time and in the same manner as the underlying restricted stock units originally awarded on January 21, 2015 and reported on Form 4 filed on January 23, 2015. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.